Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-01-05 Sale |
2023-01-09 9:42 pm |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director |
2,970 | $28.44 | $84,467 | 996,498 (Indirect Direct) |
View |
| 2022-08-19 Sale |
2022-08-23 4:47 pm |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director |
2,253 | $33.22 | $74,845 | 999,468 (Indirect Direct) |
View |
| 2022-02-11 Sale |
2022-02-15 6:56 pm |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO and Treasurer |
2,560 | $34.69 | $88,806 | 970,221 (Indirect Direct) |
View |
| 2022-02-09 Sale |
2022-02-11 5:20 pm |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO and Treasurer |
1,296 | $37.09 | $48,073 | 972,781 (Indirect Direct) |
View |
| 2022-01-05 Sale |
2022-01-07 6:06 pm |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO and Treasurer |
2,225 | $44.75 | $99,569 | 974,077 (Indirect Direct) |
View |
| 2021-08-19 Sale |
2021-08-23 8:24 pm |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO and Treasurer |
2,285 | $49.57 | $113,263 | 945,302 (Indirect Direct) |
View |
| 2021-03-15 Sale |
2021-03-16 7:16 pm |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO and Treasurer |
50,000 | $61.89 | $3,094,563 | 947,587 (Indirect Direct) |
View |
| 2021-02-16 Sale |
2021-02-18 6:12 pm |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO and Treasurer |
50,000 | $65.09 | $3,254,710 | 997,587 (Indirect Direct) |
View |
| 2021-02-11 Sale |
2021-02-16 7:42 pm |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO and Treasurer |
3,035 | $70.34 | $213,480 | 1,047,587 (Indirect Direct) |
View |
| 2021-02-09 Sale |
2021-02-11 7:11 pm |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO and Treasurer |
1,448 | $74.68 | $108,135 | 971,479 (Indirect Direct) |
View |
| 2021-01-15 Sale |
2021-01-20 6:46 pm |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO and Treasurer |
50,000 | $71.45 | $3,572,556 | 960,177 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-08-09 Option Award |
2022-08-11 4:12 pm |
N/A N/A |
Guardant Health Inc. | GH | Krognes Steve E. Director |
19,284 | $0 | 19,284 (Direct) |
View |
| 2022-07-19 Exercise |
2022-07-21 7:36 pm |
2022-07-19 2022-08-01 |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director |
62,500 | $0 | 1,001,721 (Direct) |
View |
| 2022-07-19 Exercise |
2022-07-21 7:36 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director |
62,500 | $0.68 | 1,001,721 (Direct) |
View |
| 2022-06-17 Option Award |
2022-06-22 5:34 pm |
N/A 2032-06-16 |
Gritstone bio Inc. | GRTS | Krognes Steve E. Director |
19,000 | $0 | 19,000 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 7:03 pm |
N/A 2032-01-02 |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO and Treasurer |
124,000 | $0 | 1,069,302 (Direct) |
View |
| 2021-06-18 Option Award |
2021-11-19 5:25 pm |
N/A 2031-06-17 |
Gritstone bio Inc. | GRTS | Krognes Steve E. Director |
19,000 | $0 | 19,000 (Direct) |
View |
| 2021-02-07 Exercise |
2021-02-11 7:11 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO and Treasurer |
4,250 | $0 | 971,479 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-06 6:55 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO and Treasurer |
120,000 | $0 | 120,000 (Direct) |
View |
| 2020-08-21 Tax Withholding |
2020-08-24 8:37 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO and Treasurer |
1,954 | $32.87 | 1,010,177 (Indirect) |
View |
| 2020-08-20 Exercise |
2020-08-24 8:37 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO and Treasurer |
5,643 | $0 | 1,010,177 (Direct) |
View |
| 2020-08-18 Option Award |
2020-08-20 6:17 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO and Treasurer |
20,000 | $0 | 20,000 (Direct) |
View |
| 2020-06-18 Option Award |
2020-06-22 5:36 pm |
N/A 2030-06-18 |
Gritstone Oncology Inc. | GRTS | Krognes Steve E. Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2020-06-09 Option Award |
2020-06-12 5:13 pm |
N/A 2030-06-09 |
Corvus Pharmaceuticals Inc. | CRVS | Krognes Steve E. Director |
15,000 | $0 | 15,000 (Direct) |
View |